The Center for Cancer and Metabolism (CCM)

CCM is funded through the National Institutes of Health/National Institute of General Medical Sciences Centers of Biomedical Research Excellence (COBRE) program. The CCM was established in 2017 with the receipt of an $11 million Phase I COBRE grant award. The CCM Phase II was renewed and started in January 2022 with additional award of $10 million.


Image
Biopharm

CCM Supports Early Research Projects

CCM is heavily focused on developing early, independent research careers. Support from the CCM, which provides rich mentoring experiences from both basic and clinical researchers, enhances success in competing for eventual independent, extramural grant support.